CTLA4 and glioblastoma: Similarly, a triple combination of oncolytic virus expressing IL-12, and anti-PD-1 plus anti-CTLA-4 antibodies synergistically cured pre-clinical murine GBM via increasing M1-like polarization and the ratio of effector T cells to Tregs (137).